FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer

The U.S. Food and Drug Administration (FDA) has approved the first treatment specifically for certain individuals with BCG-unresponsive bladder cancer. This regulatory approval represents a significant advancement in clinical options for patients facing this challenging form of cancer.